High Intensity Exercise and Improving Physical Activity Among People With Neurologic Dysfunction
About this trial
This trial is enrolling 15 participants with spinal cord injury or other neurological conditions to test the effect of a high intensity exercise program on mobility in everyday life. If included, participants will complete individualized one-hour exercise sessions (the Hawks in Motion program) twice per week for 8 weeks. Final testing of mobility, including postural stability during walking, will be performed after 10 weeks from the beginning of program involvement.
Included participants
What’s involved
Type
Details
- Participants will complete the Hawks in Motion (HIM) High Intensity Exercise program. - This involves one-hour exercise sessions twice per week for 8 weeks, incorporating aerobic and resistance training activities. - Final testing of mobility will be performed after 10 weeks.
Potential benefits
Main benefits
Standing/walking/mobility
Additional benefits
Arm/hand function
General health
Mental health and psychosocial factors
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life supports SCITrialsFinder
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more- Trial recruitment status
- Ended
- Trial start date
- 24 Feb 2025
- Organisation
- University of Hartford
- Trial recruitment status
- Ended
- Trial start date
- 24 Feb 2025
- Organisation
- University of Hartford
About this trial
Included participants
What’s involved
Potential benefits
Wings for Life supports SCITrialsFinder
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more